Skip to content

Study to compare the efficacy and impact on quality of life of two types of repetitive transcranial magnetic stimulation in chronic migraine patients

To study the efficacy and impact on quality of life of repetitive transcranial magnetic stimulation in chronic migraine patients- A Randomised Open labelled study - Nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064293
Enrollment
50
Registered
2024-03-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G437- Chronic migraine without aura

Interventions

Intervention1: Repetitive Transcranial Magnetic Stimulation: The Repetitive Transcranial Magnetic Stimulation will be applied using applied using Magstim Rapid-2 (Whiteland, Walsh, UK) with an air-coo

Sponsors

Institute of Medical Sciences Banaras Hindu University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with migraine without aura with duration of symptoms for more than 15 days in a month for 3 months; non-responsive to medical treatment and willing to give consent will be included in the study.

Exclusion criteria

Exclusion criteria: Patients with headache secondary to Chronic tension-type and medication overuse Patients with abnormal computed tomography (CT) or magnetic resonance imaging (MRI) of the brain or with abnormal conventional EEG Patients with depression as determined by Hamilton Depression scale Patients with secondary causes of Headache Pregnant females Patients with epilepsy or family history of epilepsy Patients with a pacemaker, intracranial metal objects, and artificial metal tooth will be excluded also from the study

Design outcomes

Primary

MeasureTime frame
To look for severity of headache reduction between both the groupsTimepoint: 1 and 3 months

Secondary

MeasureTime frame
To look for improvement in quality of life after treatment between both the groupsTimepoint: 3 and 6 months

Countries

India

Contacts

Public ContactR N Chaurasia

Banaras Hindu University

goforrameshwar@gmail.com9417926902

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026